IDXX vs. IQV

Last updated Jun 3, 2026

IDXX (IDEXX Laboratories, Inc.) and IQV (IQVIA Holdings Inc.) are both stocks. Both operate in the Diagnostics & Research industry within the Healthcare sector. Over the past 10 years, IDXX returned 20.12%/yr vs 10.39%/yr for IQV. A 0.51 correlation means they provide meaningful diversification when combined.

Performance

IDXX vs. IQV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEXX Laboratories, Inc. (IDXX) and IQVIA Holdings Inc. (IQV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IDXX achieves a -18.58% return, which is significantly higher than IQV's -19.86% return. Over the past 10 years, IDXX has outperformed IQV with an annualized return of 20.12%, while IQV has yielded a comparatively lower 10.39% annualized return.

IDXX

• 1D: -2.82%
• 1M: -2.93%
• YTD: -18.58%
• 6M: -24.83%
• 1Y: 7.00%
• 3Y*: 5.37%
• 5Y*: 0.02%
• 10Y*: 20.12%

IQV

• 1D: -3.31%
• 1M: 14.50%
• YTD: -19.86%
• 6M: -19.94%
• 1Y: 29.86%
• 3Y*: -3.56%
• 5Y*: -4.99%
• 10Y*: 10.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

IDXX vs. IQV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
IDXX IDEXX Laboratories, Inc.	-18.58%	63.63%	-25.51%	36.06%	-38.04%	31.73%	91.43%	40.38%	18.95%	33.35%
IQV IQVIA Holdings Inc.	-19.86%	14.71%	-15.07%	12.93%	-27.38%	57.47%	15.96%	33.00%	18.66%	28.73%

Correlation

The correlation between IDXX and IQV is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.44
Correlation (3Y) Calculated over the trailing 3-year period	0.46
Correlation (5Y) Calculated over the trailing 5-year period	0.57
Correlation (10Y) Calculated over the trailing 10-year period	0.55
Correlation (All Time) Calculated using the full available price history since May 10, 2013	0.51

The correlation between IDXX and IQV shifts across timeframes, from 0.44 (1 year) to 0.57 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS IDXX : $18.08 IQV : $8.07
PE Ratio IDXX : 30.47 IQV : 22.39
PEG Ratio IDXX : 2.63 IQV : 1.82
PS Ratio IDXX : 7.51 IQV : 1.86
Total Revenue (TTM) IDXX : $4.45B IQV : $16.63B
Gross Profit (TTM) IDXX : $2.76B IQV : $4.34B
EBITDA (TTM) IDXX : $1.52B IQV : $3.52B

Return for Risk

IDXX vs. IQV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDXX

IDXX Risk / Return Rank: 46
IDXX Sharpe Ratio Rank: 46
IDXX Sortino Ratio Rank: 46
IDXX Omega Ratio Rank: 45
IDXX Calmar Ratio Rank: 46
IDXX Martin Ratio Rank: 46

IQV

IQV Risk / Return Rank: 60
IQV Sharpe Ratio Rank: 63
IQV Sortino Ratio Rank: 60
IQV Omega Ratio Rank: 61
IQV Calmar Ratio Rank: 57
IQV Martin Ratio Rank: 56

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDXX vs. IQV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and IQVIA Holdings Inc. (IQV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IDXX	IQV	Difference
Sharpe ratio Return per unit of total volatility	0.17	0.72	-0.55
Sortino ratio Return per unit of downside risk	0.70	1.30	-0.60
Omega ratio Gain probability vs. loss probability	1.09	1.18	-0.09
Calmar ratio Return relative to maximum drawdown	0.24	0.80	-0.57
Martin ratio Return relative to average drawdown	0.50	1.64	-1.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IDXX vs. IQV - Sharpe Ratio Comparison

The current IDXX Sharpe Ratio is 0.17, which is lower than the IQV Sharpe Ratio of 0.72. The chart below compares the historical Sharpe Ratios of IDXX and IQV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	IDXX	IQV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.17	0.72	-0.55
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.00	-0.15	+0.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.61	0.33	+0.28
Sharpe Ratio (All Time) Calculated using the full available price history	0.51	0.40	+0.11

Drawdowns

IDXX vs. IQV - Drawdown Comparison

The maximum IDXX drawdown since its inception was -81.42%, which is greater than IQV's maximum drawdown of -51.52%. Use the drawdown chart below to compare losses from any high point for IDXX and IQV.

Drawdown Indicators

	IDXX	IQV	Difference
Max Drawdown Largest peak-to-trough decline	-81.42%	-51.52%	-29.90%
Max Drawdown (1Y) Largest decline over 1 year	-31.04%	-35.87%	+4.83%
Max Drawdown (3Y) Largest decline over 3 years	-37.41%	-47.12%	+9.71%
Max Drawdown (5Y) Largest decline over 5 years	-54.00%	-51.52%	-2.48%
Max Drawdown (10Y) Largest decline over 10 years	-54.00%	-51.52%	-2.48%
Current Drawdown Current decline from peak	-28.16%	-36.08%	+7.92%
Average Drawdown Average peak-to-trough decline	-21.00%	-12.76%	-8.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.65%	17.52%	-2.87%

Volatility

IDXX vs. IQV - Volatility Comparison

The current volatility for IDEXX Laboratories, Inc. (IDXX) is 8.93%, while IQVIA Holdings Inc. (IQV) has a volatility of 15.19%. This indicates that IDXX experiences smaller price fluctuations and is considered to be less risky than IQV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IDXX	IQV	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.93%	15.19%	-6.26%
Volatility (6M) Calculated over the trailing 6-month period	20.04%	31.65%	-11.61%
Volatility (1Y) Calculated over the trailing 1-year period	41.39%	41.76%	-0.37%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.27%	33.45%	+1.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.01%	31.72%	+1.29%

Dividends

IDXX vs. IQV - Dividend Comparison

Neither IDXX nor IQV has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

IDXX vs. IQV - Profitability Comparison

The chart below illustrates the profitability comparison between IDEXX Laboratories, Inc. and IQVIA Holdings Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

IDXX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.

IQV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IQVIA Holdings Inc. reported a gross profit of 1.36B and revenue of 4.15B. Therefore, the gross margin over that period was 32.6%.

IDXX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.

IQV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IQVIA Holdings Inc. reported an operating income of 514.00M and revenue of 4.15B, resulting in an operating margin of 12.4%.

IDXX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.

IQV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IQVIA Holdings Inc. reported a net income of 274.00M and revenue of 4.15B, resulting in a net margin of 6.6%.

Frequently Asked Questions

Can I hold both IDXX and IQV in my portfolio?

IDXX and IQV have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IDXX or IQV?

IQV has higher volatility (15.19%) compared to IDXX (8.93%). In terms of maximum drawdown, IDXX dropped -81.42% vs IQV's -51.52%.

Which has better risk-adjusted returns?

IQV currently has the higher Sharpe Ratio (0.72 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.